Stock AnalizTenet Healthcare (THC) earnings for the quarter ended September 2026: EPS beats estimates
Tenet Healthcare reported results for the quarter ended September 2026 on October 29, 2026. Adjusted earnings per share came in at $6.64 against the analysts’ average forecast of $4.68, a beat of 42.0%.
Revenue for the quarter was $5.63 billion, up 6.5% from $5.29 billion in the same quarter a year earlier.
The market’s verdict: the stock rose 0.8% on the first trading day after the report.
The last four quarters
Tenet Healthcare has beaten the analysts’ EPS forecast in 4 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $6.64 | $4.68 | +42.0% | +6% | +0.8% |
| Jun 2026 | $6.12 | $4.26 | +43.5% | +7% | +19.4% |
| Mar 2026 | $4.82 | $4.17 | +15.7% | +3% | +1.8% |
| Dec 2025 | $4.70 | $4.07 | +15.6% | +9% | +20.3% |
What comes next
Analysts expect EPS of $5.29 for the next quarter on average and $22.71 for the fiscal year ending December 31, 2026.
The average analyst price target is $306.18, 7% above the current price of $286.03.
Valuation and score
Tenet Healthcare scores 2.8 out of 5 overall on Stock Analiz (average), trades at a trailing P/E of about 8.3, and its intrinsic value under moderate assumptions is about 31% above the current market value. Full Tenet Healthcare analysis with 10 years of financials
Frequently asked questions
What was Tenet Healthcare’s EPS for the quarter ended September 2026?
$6.64 adjusted per share, against an analyst consensus of $4.68.
How much revenue did Tenet Healthcare report?
$5.63 billion, up 6.5% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.